Effect of Short-term Homebased Pre- and Postoperative Exercise on Recovery After Colorectal Cancer Surgery (PHYSSURG-C): A Randomized Clinical Trial.

Authors:
Onerup A; Andersson J; Angenete E; Bock D; Börjesson M and 6 more

Journal:
Ann Surg

Publication Year: 2022

DOI:
10.1097/SLA.0000000000004901

PMCID:
PMC8820776

PMID:
33843798

Journal Information

Full Title: Ann Surg

Abbreviation: Ann Surg

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: General Surgery

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
5/6
83.3% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"data sharing proposals should be sent to the corresponding author. this study was funded by grants from the afa insurance (150072"

Code Sharing
Evidence found in paper:

"The authors report no conflicts of interest."

Evidence found in paper:

"This study was funded by grants from the AFA Insurance (150072), the Swedish state under the agreement between the Swedish government and the county councils, the ALF-agreement (ALFGBG-718221, ALFGBG-4307771, ALFGBG-493341, and ALFGBG-784821), the Swedish Cancer Society (CAN 2016/519; 2019/190303), Assar Gabrielsson's Foundation (FB19-07 and FB 16-95), Anna-Lisa and Bror Björnsson's Foundation, Dr Felix Neubergh's Foundation (2017-347), Gothenburg Medical Society (GLS-688001, GLS-778731, and GLS-883991), Lions Cancer Fund West (2019:6), Mary von Sydow's Foundation (1216), the Swedish Society of Medicine (SLS-499811), and the Healthcare Committee Region Västra Götaland (Hälso-och Sjukvårdsstyrelsen) (VGFOUREG-309261, VGRFOUREG-659011, VGRFOUREG-837542, and VGRFOUREG-739191). The funders of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication. All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: JA, EA, DB, MB, CE, MFO, PAL, HN, and AW declare no support from any organization for the submitted work: AO reports grants from the Swedish state under the agreement between the Swedish government and the county councils, the ALF-agreement, grants from Assar Gabrielsson's Foundation, grants from Anna-Lisa and Bror Björnsson's Foundation, grants from Dr Felix Neubergh's Foundation, grants from Gothenburg Medical Society, grants from Lions Cancer Fund West during the conduct of the study: EH reports grants from AFA Insurance and grants from the Swedish state under the agreement between the Swedish government and the county councils, the ALF-agreement, and grants from the Swedish Cancer Society during the conduct of the study; AO, JA, EA, DB, MB, CE, MFO, PAL, HN, and AW declare no financial relationships with any organizations that might have an interest in the submitted work in the previous 3 years: EH reports grants from Mary von Sydow Foundation, grants from the Swedish Research Council, and grants from Göteborg Medical Society outside the submitted work; all authors report no other relationships or activities that could appear to have influenced the submitted work. All authors confirm that they had full access to all the data in the study and accept responsibility to submit for publication."

Evidence found in paper:

"A randomized, controlled, open-label, multicenter, superiority trial was performed. Participants were recruited at 5 regional and 1 university hospital in Sweden. The study was designed as a pragmatic trial rather than an explanatory trial, assessed using PRECIS-2. Ethical permission was obtained from the Regional Ethics Board in Gothenburg (2014-10-30, DNR:597-14). The study protocol has been published and is also available at www.ssorg.net. The study was registered at ClinicalTrials.gov with trial registration number NCT02299596, date of first registry was November 17, 2014."

Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025